Amgen Income Statement
AMGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Amgen reported $36.8B in revenue and $7.7B in net income for FY2025. Revenue has grown at a 6.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.8B | $33.4B | $28.2B | $26.3B | $26.0B | $25.4B | $22.8B | $23.0B | $21.7B | $20.1B | $21.7B | $17.3B | $18.7B | $17.3B | $15.6B |
| Cost of Revenue | $12.0B | $12.9B | $8.5B | $6.4B | $6.5B | $6.2B | $4.1B | $4.2B | $4.2B | $4.4B | $4.2B | $3.2B | $3.3B | $3.2B | $2.7B |
| Gross Profit | - | - | - | - | - | - | $4.2B | $4.4B | $4.2B | $4.2B | $3.8B | $3.3B | $3.4B | $3.2B | $3.1B |
| SG&A Expense | $7.0B | $7.1B | $6.2B | $5.4B | $5.4B | $5.7B | $4.9B | $5.1B | $4.8B | $4.7B | $4.8B | $4.8B | $5.2B | $4.8B | $4.5B |
| R&D Expense | $7.3B | $6.0B | $4.8B | $4.4B | $4.8B | $4.2B | $3.6B | $3.8B | $4.1B | $4.3B | $4.1B | $3.4B | $4.1B | $3.4B | $3.2B |
| Operating Income | $9.1B | $7.3B | $7.9B | $9.6B | $7.6B | $9.1B | $10.0B | $9.8B | $8.5B | $6.2B | $8.5B | $5.6B | $5.9B | $5.6B | $4.3B |
| Interest Expense | $2.8B | $3.2B | $2.9B | $1.4B | $1.2B | $1.3B | $1.3B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $1.1B | $610.0M |
| Income Tax | $1.3B | $519.0M | $1.1B | $794.0M | $808.0M | $869.0M | $7.6B | $1.4B | $1.0B | $427.0M | $1.0B | $664.0M | $184.0M | $664.0M | $467.0M |
| Net Income | $7.7B | $4.1B | $6.7B | $6.6B | $5.9B | $7.3B | $2.0B | $7.7B | $6.9B | $5.2B | $6.9B | $4.3B | $5.1B | $4.3B | $3.7B |
| EPS (Basic) | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 | $12.40 | $2.71 | $10.32 | $9.15 | $6.80 | $6.75 | $5.61 | $4.07 | $4.82 | $4.53 |
| EPS (Diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $2.69 | $10.24 | $9.06 | $6.70 | $6.64 | $5.52 | $4.04 | $4.79 | $4.51 |
| Shares Outstanding | 538.8M | 536.9M | 535.4M | 534.0M | 558.3M | 578.3M | 629.6M | 722.2M | 738.2M | 754.0M | 760.4M | 754.6M | 756.3M | 795.6M | 932.1M |
| Gross Margin | - | - | - | - | - | - | 18.5% | 19.1% | 19.4% | 21.0% | 17.7% | 18.9% | 18.2% | 18.7% | 19.6% |
| Operating Margin | 24.7% | 21.7% | 28.0% | 36.3% | 29.4% | 35.9% | 43.6% | 42.6% | 39.1% | 30.9% | 39.1% | 32.3% | 31.4% | 32.3% | 27.7% |
| Profit Margin | 21.0% | 12.2% | 23.8% | 24.9% | 22.7% | 28.6% | 8.7% | 33.6% | 32.0% | 25.7% | 32.0% | 25.2% | 27.2% | 25.2% | 23.6% |